Breast Cancer: The Value of Preoperative Chemotherapy

By Singletary S.E.  

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 121-126

Adis International

Access to resources Recommend Favorite

Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients

By Gilje Bjørnar   Nordgård Oddmund   Tjensvoll Kjersti   Janssen Emiel   Søiland Håvard   Smaaland Rune   Baak Jan  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 137-146

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer - the role of clinical response

By Pierga J.-Y.   Mouret E.   Laurence V.   Dieras V.   Savigioni A.   Beuzeboc P.   Dorval T.   Palangie T.   Jouve M.   Pouillart P.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1089-1096

Elsevier

Access to resources Recommend Favorite

High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer

By Abrial Sophie   Penault-Llorca Frédérique   Delva Rémi   Bougnoux Philippe   Leduc Bernard   Mouret-Reynier Marie-Ange   Mery-Mignard Dominique   Bleuse Jean-Pierre   Dauplat Jacques   Curé Hervé   Chollet Philippe  

Breast Cancer Research and Treatment, Vol. 94, Iss. 3, 2005-12 ,pp. : 255-263

Springer Publishing Company

Access to resources Recommend Favorite

The prognostic value of apoptotic and proliferative markers in breast cancer

By Engels Charla   Ruberta Francesca   Kruijf Esther   Pelt Gabi   Smit Vincent   Liefers Gerrit   Matsushima Tomoko   Shibayama Masaki   Ishihara Hideki   Velde Cornelis   Kuppen Peter  

Breast Cancer Research and Treatment, Vol. 142, Iss. 2, 2013-11 ,pp. : 323-339

Springer Publishing Company

Access to resources Recommend Favorite